REPORT ID 2580

Global Meningioma Drug Market Research Report 2017

Publish Date
11-Dec-17
Pages
115
Format
Electronic (PDF)

In this report, the global Meningioma Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Meningioma Drug in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Meningioma Drug market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Arno Therapeutics Inc
    AstraZeneca Plc
    Boehringer Ingelheim GmbH
    Eli Lilly and Co
    Genentech Inc
    GlaxoSmithKline Plc
    Merck & Co Inc
    Merck KGaA
    Novartis AG
    Ono Pharmaceutical Co Ltd
    Pharma Mar SA
    Progenics Pharmaceuticals Inc
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Abemaciclib
    Afatinib Dimaleate
    AR-42
    Avelumab
    Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Hospital
    Clinic
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Meningioma Drug Market Research Report 2017
1 Meningioma Drug Market Overview
    1.1 Product Overview and Scope of Meningioma Drug
    1.2 Meningioma Drug Segment by Type (Product Category)
        1.2.1 Global Meningioma Drug Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Meningioma Drug Production Market Share by Type (Product Category) in 2016
        1.2.3 Abemaciclib
        1.2.4 Afatinib Dimaleate
        1.2.5 AR-42
        1.2.6 Avelumab
        1.2.7 Others
    1.3 Global Meningioma Drug Segment by Application
        1.3.1 Meningioma Drug Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Global Meningioma Drug Market by Region (2012-2022)
        1.4.1 Global Meningioma Drug Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Meningioma Drug (2012-2022)
        1.5.1 Global Meningioma Drug Revenue Status and Outlook (2012-2022)
        1.5.2 Global Meningioma Drug Capacity, Production Status and Outlook (2012-2022)

2 Global Meningioma Drug Market Competition by Manufacturers
    2.1 Global Meningioma Drug Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Meningioma Drug Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Meningioma Drug Production and Share by Manufacturers (2012-2017)
    2.2 Global Meningioma Drug Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Meningioma Drug Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Meningioma Drug Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Meningioma Drug Market Competitive Situation and Trends
        2.5.1 Meningioma Drug Market Concentration Rate
        2.5.2 Meningioma Drug Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Meningioma Drug Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Meningioma Drug Capacity and Market Share by Region (2012-2017)
    3.2 Global Meningioma Drug Production and Market Share by Region (2012-2017)
    3.3 Global Meningioma Drug Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Meningioma Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Meningioma Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Meningioma Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Meningioma Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Meningioma Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Meningioma Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Meningioma Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Meningioma Drug Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Meningioma Drug Consumption by Region (2012-2017)
    4.2 North America Meningioma Drug Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Meningioma Drug Production, Consumption, Export, Import (2012-2017)
    4.4 China Meningioma Drug Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Meningioma Drug Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Meningioma Drug Production, Consumption, Export, Import (2012-2017)
    4.7 India Meningioma Drug Production, Consumption, Export, Import (2012-2017)

5 Global Meningioma Drug Production, Revenue (Value), Price Trend by Type
    5.1 Global Meningioma Drug Production and Market Share by Type (2012-2017)
    5.2 Global Meningioma Drug Revenue and Market Share by Type (2012-2017)
    5.3 Global Meningioma Drug Price by Type (2012-2017)
    5.4 Global Meningioma Drug Production Growth by Type (2012-2017)

6 Global Meningioma Drug Market Analysis by Application
    6.1 Global Meningioma Drug Consumption and Market Share by Application (2012-2017)
    6.2 Global Meningioma Drug Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Meningioma Drug Manufacturers Profiles/Analysis
    7.1 Arno Therapeutics Inc
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Meningioma Drug Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Arno Therapeutics Inc Meningioma Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 AstraZeneca Plc
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Meningioma Drug Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 AstraZeneca Plc Meningioma Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Boehringer Ingelheim GmbH
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Meningioma Drug Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Boehringer Ingelheim GmbH Meningioma Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Eli Lilly and Co
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Meningioma Drug Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Eli Lilly and Co Meningioma Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Genentech Inc
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Meningioma Drug Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Genentech Inc Meningioma Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 GlaxoSmithKline Plc
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Meningioma Drug Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 GlaxoSmithKline Plc Meningioma Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Merck & Co Inc
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Meningioma Drug Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Merck & Co Inc Meningioma Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Merck KGaA
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Meningioma Drug Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Merck KGaA Meningioma Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Novartis AG
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Meningioma Drug Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Novartis AG Meningioma Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Ono Pharmaceutical Co Ltd
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Meningioma Drug Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Ono Pharmaceutical Co Ltd Meningioma Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 Pharma Mar SA
    7.12 Progenics Pharmaceuticals Inc

8 Meningioma Drug Manufacturing Cost Analysis
    8.1 Meningioma Drug Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Meningioma Drug

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Meningioma Drug Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Meningioma Drug Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Meningioma Drug Market Forecast (2017-2022)
    12.1 Global Meningioma Drug Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Meningioma Drug Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Meningioma Drug Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Meningioma Drug Price and Trend Forecast (2017-2022)
    12.2 Global Meningioma Drug Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Meningioma Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Meningioma Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Meningioma Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Meningioma Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Meningioma Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Meningioma Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Meningioma Drug Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Meningioma Drug Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer